Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022
Current assets
Cash and cash equivalents	$ 961	$ 1,524
Restricted cash	545
Note receivable	1,300
Prepaid expenses and other current assets	278	416
Assets held for sale	10,235	29,013
Total current assets	13,319	30,953
Total assets	13,347	30,981
Current liabilities
Accounts payable and accrued expenses	1,399	1,267
Convertible notes, net	2,111	1,073
Short term notes and advances	229	438
Derivative liability	448	370
Warrant liability	134	55
Liabilities held for sale	9,657	10,741
Total current liabilities	13,978	13,944
Total liabilities	13,978	13,944
Commitments and contingencies (Note 17)
Shareholders’ equity
Preferred stock value
Common stock, $0.001 par value; 750,000,000 shares authorized; 2,810,094 and 2,270,140 shares issued, issuable and outstanding as of September 30, 2023 and September 30, 2022, respectively	3	2
Additional paid-in capital	150,471	148,675
Distribution	(56)
Accumulated deficit	(152,136)	(133,118)
Total Stem Holdings stockholder’s equity	(1,718)	15,559
Noncontrolling interest	1,087	1,478
Total shareholders’ equity (deficit)	(631)	17,037
Total liabilities and shareholders’ equity	13,347	30,981
Series A Preferred Stock [Member]
Shareholders’ equity
Preferred stock value
Series B Preferred Stock [Member]
Shareholders’ equity
Preferred stock value
Related Party [Member]
Current assets
Due from related party	$ 28	$ 28